Filing Details
- Accession Number:
- 0001079973-23-001645
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-22 16:10:27
- Reporting Period:
- 2023-11-20
- Accepted Time:
- 2023-11-22 16:10:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1426800 | Assembly Biosciences Inc. | ASMB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1999256 | Alexander Schornstein | Kaiser-Friedrich-Allee 2 Aachen 2M 52074 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-20 | 300,000 | $0.72 | 7,464,292 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-11-21 | 100,000 | $0.67 | 7,564,292 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds.
- The price reported is a weighted average price. These shares were purchased on November 20, 2023, in multiple transactions at prices ranging from $0.695 to $0.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
- The 100,000 shares purchased on November 21, 2023, were bought in transactions at prices ranging from $0.6666 to $0.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Billionaire Hedge Funds
